PET imaging of cholinergic neurotransmission in neurodegenerative disorders

S Tiepolt, PM Meyer, M Patt… - Journal of Nuclear …, 2022 - Soc Nuclear Med
As a neuromodulator, the neurotransmitter acetylcholine plays an important role in cognitive,
mood, locomotor, sleep/wake, and olfactory functions. In the pathophysiology of most …

[HTML][HTML] PET agents in dementia: an overview

A van Waarde, S Marcolini, PP De Deyn… - Seminars in Nuclear …, 2021 - Elsevier
This article presents an overview of imaging agents for PET that have been applied for
research and diagnostic purposes in patients affected by dementia. Classified by the target …

[HTML][HTML] Advances in small molecule selective ligands for heteromeric nicotinic acetylcholine receptors

C Matera, C Papotto, C Dallanoce… - Pharmacological Research, 2023 - Elsevier
The study of nicotinic acetylcholine receptors (nAChRs) has significantly progressed in the
last decade, due to a) the improved techniques available for structural studies; b) the …

Recent topics of the clinical utility of PET/MRI in oncology and neuroscience

Y Nakamoto, K Kitajima, A Toriihara, M Nakajo… - Annals of Nuclear …, 2022 - Springer
Since the inline positron emission tomography (PET)/magnetic resonance imaging (MRI)
system appeared in clinical, more than a decade has passed. In this article, we have …

A molecular toolbox of positron emission tomography tracers for general anesthesia mechanism research

X Wang, T Wang, X Fan, Z Zhang… - Journal of Medicinal …, 2023 - ACS Publications
With appropriate radiotracers, positron emission tomography (PET) allows direct or indirect
monitoring of the spatial and temporal distribution of anesthetics, neurotransmitters, and …

[HTML][HTML] Turning the spotlight to cholinergic pharmacotherapy of the human language system

G Dávila, MJ Torres-Prioris, D López-Barroso… - CNS drugs, 2023 - Springer
Even though language is essential in human communication, research on pharmacological
therapies for language deficits in highly prevalent neurodegenerative and vascular brain …

Neuroproteomics Chip-Based Mass Spectrometry and Other Techniques for Alzheimer's Disease Biomarkers–Update

AB Pomilio, AA Vitale… - Current Pharmaceutical …, 2022 - ingentaconnect.com
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disease of
growing interest given that there is cognitive damage and symptom onset acceleration …

Association of CSF sTREM2, a marker of microglia activation, with cholinergic basal forebrain volume in major depressive disorder

S Teipel, D Bruno, CR Plaska, A Heslegrave… - Journal of affective …, 2021 - Elsevier
Background Inflammatory mechanisms are believed to contribute to the manifestation of
major depressive disorder (MDD). Central cholinergic activity may moderate this effect …

[HTML][HTML] Imaging of Tauopathies with PET Ligands: State of the Art and Future Outlook

M Conte, MS De Feo, MMA Sidrak, F Corica, J Gorica… - Diagnostics, 2023 - mdpi.com
(1) Background: Tauopathies are a group of diseases characterized by the deposition of
abnormal tau protein. They are distinguished into 3R, 4R, and 3R/4R tauopathies and also …

Cholinergic Imaging and Dementia

N Okkels, J Horsager, N Pavese, DJ Brooks… - Molecular Imaging of …, 2023 - Springer
There is evidence of early pathological changes in cholinergic neurons of patients with
Alzheimer's disease and Lewy body disease. This makes cholinergic molecular imaging one …